Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1983-2-25
|
pubmed:abstractText |
The concomitant protective effects of the aldose reductase inhibitor, 7-dimethylsulfamoyl-xanthone-2-carboxylic acid, were established by three lens parameters (soluble crystallin proteins, growth and cell hydration) because their quantitation provided a comprehensive index of lens physiology during sugar cataractogenesis in the rat neonate. Their fused eyelids provided the orbital pouch for topical administration of inhibitor to the treated lens; the contralateral pouch served as an untreated control. Protein preservation was determined by gel filtration chromatography. In galactose-maintained neonates, untreated lenses exhibited only 50% of the normal Fraction II protein whereas xanthone-treatment maintained 73% of this component. Quantitative analysis of scanning electron micrographs indicated that xanthone-treatment partially protected lenses against both intra and extracellular fluid accumulation as determined by measurements of individual fiber cell thickness, density (the number of cells/10 micron cortex), and interdigitation. In addition, xanthone-treatment improved lens growth as evidenced by radius and dry weight measurements. Our results suggest that topically applied xanthone partially inhibited sugar cataractogenesis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldehyde Reductase,
http://linkedlifedata.com/resource/pubmed/chemical/Crystallins,
http://linkedlifedata.com/resource/pubmed/chemical/Galactose,
http://linkedlifedata.com/resource/pubmed/chemical/Sugar Alcohol Dehydrogenases,
http://linkedlifedata.com/resource/pubmed/chemical/Xanthenes,
http://linkedlifedata.com/resource/pubmed/chemical/Xanthones
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0301-4533
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
259
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
166-76
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:6817723-Aldehyde Reductase,
pubmed-meshheading:6817723-Animals,
pubmed-meshheading:6817723-Animals, Newborn,
pubmed-meshheading:6817723-Body Water,
pubmed-meshheading:6817723-Cataract,
pubmed-meshheading:6817723-Crystallins,
pubmed-meshheading:6817723-Diabetes Mellitus, Experimental,
pubmed-meshheading:6817723-Galactose,
pubmed-meshheading:6817723-Lens, Crystalline,
pubmed-meshheading:6817723-Rats,
pubmed-meshheading:6817723-Sugar Alcohol Dehydrogenases,
pubmed-meshheading:6817723-Xanthenes,
pubmed-meshheading:6817723-Xanthones
|
pubmed:year |
1982
|
pubmed:articleTitle |
Xanthone-2-carboxylic acid effect on lens growth, hydration and proteins during diabetic cataract development.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|